Kneat Posts Record Revenue Growth in 2025 as Life Sciences Software Demand Surges
Event summary
- Kneat reported a 24% year-over-year revenue increase to $17.0 million in Q4 2025, with full-year revenues rising 29% to $63.3 million.
- SaaS revenue grew 29% in Q4 and 33% for the full year, reaching $16.2 million and $59.4 million respectively.
- Annual Recurring Revenue (ARR) hit $74.1 million at year-end 2025, up 24% from $59.7 million in 2024.
- Kneat achieved positive Adjusted EBITDA for the second consecutive year, with Q4 2025 adjusted EBITDA reaching $4.2 million.
The big picture
Kneat's strong financial performance in 2025 reflects the growing demand for digital validation and compliance solutions in the life sciences sector. The company's strategic partnerships, such as with Capgemini, and product innovations position it well to capitalize on industry trends towards automation and data integrity. With a solid balance sheet and expanding footprint, Kneat is poised to outpace previous growth rates in 2026.
What we're watching
- Execution Risk
- Whether Kneat can sustain its growth momentum and achieve cash-flow breakeven in 2026 as projected.
- Market Expansion
- The pace at which Kneat can expand its customer base, particularly among large life sciences companies.
- Product Innovation
- How the integration of AI features into the Kneat Gx platform will impact customer adoption and revenue growth.
Related topics